The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Smith, G. P. (1985) · Science · doi:10.1126/science.4001944 · Cited by 4,143
Making antibodies by phage display technology
Winter, G., Griffiths, A. D., Hawkins, R. E., & Hoogenboom, H. R. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.002245 · Cited by 1,573
Sulakvelidze, A., Alavidze, Z., & Morris, J. G. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.649-659.2001 · Cited by 1,566
Bacteriophages: Biology and Applications
Silver, S., & Baylor, M. (2006) · Microbe Magazine · doi:10.1128/microbe.1.151.1 · Cited by 570
Human Volunteers Receiving Escherichia coli Phage T4 Orally: a Safety Test of Phage Therapy
Bruttin, A., & Brüssow, H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2874-2878.2005 · Cited by 563
Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display.
Rajotte, D., Arap, W., Hagedorn, M., Koivunen, E., Pasqualini, R., & Ruoslahti, E. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3008 · Cited by 457
Bacteriophage lytic enzymes: novel anti-infectives
Fischetti, V. A. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2005.08.007 · Cited by 400
Barry, M. A., Dower, W. J., & Johnston, S. A. (1996) · Nature Medicine · doi:10.1038/nm0396-299 · Cited by 338
Bacteriophage therapy of infectious diseases in aquaculture
Nakai, T., & Park, S. C. (2002) · Research in Microbiology · doi:10.1016/s0923-2508(01)01280-3 · Cited by 276
Phage display for detection of biological threat agents
Petrenko, V. A., & Vodyanoy, V. J. (2003) · Journal of Microbiological Methods · doi:10.1016/s0167-7012(03)00029-0 · Cited by 263
Cited by
Alternatives to Conventional Antibiotics in the Era of Antimicrobial Resistance
Ghosh, C., Sarkar, P., Issa, R., & Haldar, J. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2018.12.010 · Cited by 661
Defoirdt, T., Boon, N., Sorgeloos, P., Verstraete, W., & Bossier, P. (2007) · Trends in Biotechnology · doi:10.1016/j.tibtech.2007.08.001 · Cited by 379
Phage Therapy in the Food Industry
Endersen, L., O'Mahony, J., Hill, C., Ross, R. P., McAuliffe, O., & Coffey, A. (2014) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-030713-092415 · Cited by 338
Biotechnological applications of bacteriophages: State of the art
Harada, L. K., Silva, E. C., Campos, W. F., Del Fiol, F. S., Vila, M., Dąbrowska, K., Krylov, V. N., & Balcão, V. M. (2018) · Microbiological Research · doi:10.1016/j.micres.2018.04.007 · Cited by 318
Bacteriophages and their implications on future biotechnology: a review
Haq, I. U., Chaudhry, W. N., Akhtar, M. N., Andleeb, S., & Qadri, I. (2012) · Virology Journal · doi:10.1186/1743-422x-9-9 · Cited by 304
Kumar, V., Roy, S., Behera, B. K., Bossier, P., & Das, B. K. (2021) · Toxins · doi:10.3390/toxins13080524 · Cited by 293
The Art of Engineering Viral Nanoparticles
Pokorski, J. K., & Steinmetz, N. F. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100225y · Cited by 266
Bacteriophage virion-associated peptidoglycan hydrolases: potential new enzybiotics
Rodríguez-Rubio, L., Martínez, B., Donovan, D. M., Rodríguez, A., & García, P. (2013) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2012.723675 · Cited by 173
Costa, P., Gomes, A. T. P. C., Braz, M., Pereira, C., & Almeida, A. (2021) · Antibiotics · doi:10.3390/antibiotics10080974 · Cited by 77
Metadata
- Authors
- Clark, J. R., & March, J. B.
- Venue
- Trends in Biotechnology
- Publisher
- Elsevier BV
- Published
- 2006-05
- Volume
- 24
- Issue
- 5
- Pages
- 212-218
- ISSN
- 0167-7799 (ISSN-L)
- OpenAlex
- W2085562160
- Cited by
- 343
- References
- 40
- FWCI
- 1.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.